Cargando…
Systemic metastasis-targeted nanotherapeutic reinforces tumor surgical resection and chemotherapy
Failure of conventional clinical therapies such as tumor resection and chemotherapy are mainly due to the ineffective control of tumor metastasis. Metastasis consists of three steps: (i) tumor cells extravasate from the primary sites into the circulation system via epithelial-mesenchymal transition...
Autores principales: | Xu, Minjun, Hu, Kaili, Liu, Yipu, Huang, Yukun, Liu, Shanshan, Chen, Yu, Wang, Dayuan, Zhou, Songlei, Zhang, Qian, Mei, Ni, Lu, Huiping, Li, Fengan, Gao, Xiaoling, Chen, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160269/ https://www.ncbi.nlm.nih.gov/pubmed/34045459 http://dx.doi.org/10.1038/s41467-021-23466-5 |
Ejemplares similares
-
Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment
por: Jiang, Tianze, et al.
Publicado: (2022) -
Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma
por: Zhou, Songlei, et al.
Publicado: (2023) -
Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics
por: Zou, Lili, et al.
Publicado: (2016) -
Advances in personalized nanotherapeutics
por: Kaushik, Ajeet, et al.
Publicado: (2017) -
Polymeric nanomaterials for nanotherapeutics
por: Vasile, Cornelia
Publicado: (2018)